Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium
Condition(s):Transplant; Failure, KidneyLast Updated:December 15, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Transplant; Failure, KidneyLast Updated:December 15, 2016Completed
Condition(s):Advanced CancerLast Updated:December 20, 2023Active, not recruiting
Condition(s):End Stage Renal Disease (ESRD); Chronic Kidney Disease (CKD); Hemodialysis; Renal Replacement Therapy; Renal TransplantationLast Updated:January 30, 2019Completed
Condition(s):Cutaneous Squamous Cell Carcinoma; Advanced CancerLast Updated:January 25, 2024Active, not recruiting
Condition(s):Prostate CancerLast Updated:December 1, 2020Completed
Condition(s):Breast CancerLast Updated:January 28, 2021Terminated
Condition(s):End Stage Renal Failure With Renal TransplantLast Updated:March 2, 2021Completed
Condition(s):Breast CancerLast Updated:May 28, 2012Terminated
Condition(s):Kidney Transplant RejectionLast Updated:April 19, 2021Recruiting
Condition(s):Advanced Gastrointestinal Stromal TumorLast Updated:March 20, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.